Irene Veneziani
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells.
Journal: Frontiers in immunology
Published: January 11, 2024
Determining Endosomal Toll-Like Receptors Gene Expression in NK Cells After Stimulation with Specific Agonists.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 21, 2023
Human toll-like receptor 8 (TLR8) in NK cells: Implication for cancer immunotherapy.
Journal: Immunology letters
Published: June 21, 2023
How the Immune System Responds to Allergy Immunotherapy.
Journal: Biomedicines
Published: September 12, 2022
IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells.
Journal: Journal for immunotherapy of cancer
Published: February 17, 2022
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16- subset.
Journal: Journal for immunotherapy of cancer
Published: December 17, 2021
Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal.
Journal: Frontiers in immunology
Published: June 21, 2021
Identification of neuroblastoma cell lines with uncommon TAZ+/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells.
Journal: Journal for immunotherapy of cancer
Published: November 09, 2020
Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?
Journal: Cancers
Published: October 15, 2020
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.
Journal: Cancer immunology research
Published: April 20, 2020
Last Updated: 09/26/2026